<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE125011" accession="SRP178846">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP178846</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA514904</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE125011</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>The Role of CD83 in ovarian cancer cell line SKOV3</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>We performed RNA-Seq of CD83 overexpression SKOV3 cells (OV_1, OV_2, OV_3), CD83 knockdown SKOV3 cells (KD_1, KD_2, KD-3), and control SKOV3 cells (NC_1, NC_2, NC_3) using BGISEQ-500 platform (BGI, China). Overall design: To initiate this study, we developed human CD83 stable overexpression and knockdown sublines of SKOV3 cells, using infection of full length CD83 lentivirus (CD83-OV) and CD83-specific lentiviral shRNA (CD83-KD), respectively. LV5 or LV3 lentivirus, containing GFP and puromycin resistant site, was served as negative control (NC). Polybrene (4 µg/ml) was used to increase the lentivirus infection efficiency. GFP-positive stable transfected cell lines were generated by two rounds of puromycin (1µg/ml) selection.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE125011</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_LINKS>
      <STUDY_LINK>
        <XREF_LINK>
          <DB>pubmed</DB>
          <ID>32823589</ID>
        </XREF_LINK>
      </STUDY_LINK>
    </STUDY_LINKS>
  </STUDY>
</STUDY_SET>
